1. Home
  2. TSBX vs LDWY Comparison

TSBX vs LDWY Comparison

Compare TSBX & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSBX
  • LDWY
  • Stock Information
  • Founded
  • TSBX 2015
  • LDWY 1990
  • Country
  • TSBX United States
  • LDWY United States
  • Employees
  • TSBX N/A
  • LDWY N/A
  • Industry
  • TSBX
  • LDWY Advertising
  • Sector
  • TSBX
  • LDWY Consumer Discretionary
  • Exchange
  • TSBX Nasdaq
  • LDWY Nasdaq
  • Market Cap
  • TSBX 7.7M
  • LDWY 9.2M
  • IPO Year
  • TSBX 2023
  • LDWY 1991
  • Fundamental
  • Price
  • TSBX $0.36
  • LDWY $4.98
  • Analyst Decision
  • TSBX Buy
  • LDWY
  • Analyst Count
  • TSBX 3
  • LDWY 0
  • Target Price
  • TSBX $4.75
  • LDWY N/A
  • AVG Volume (30 Days)
  • TSBX 471.7K
  • LDWY 4.2K
  • Earning Date
  • TSBX 08-13-2025
  • LDWY 08-18-2025
  • Dividend Yield
  • TSBX N/A
  • LDWY N/A
  • EPS Growth
  • TSBX N/A
  • LDWY N/A
  • EPS
  • TSBX N/A
  • LDWY N/A
  • Revenue
  • TSBX N/A
  • LDWY $42,183,000.00
  • Revenue This Year
  • TSBX N/A
  • LDWY N/A
  • Revenue Next Year
  • TSBX N/A
  • LDWY N/A
  • P/E Ratio
  • TSBX N/A
  • LDWY N/A
  • Revenue Growth
  • TSBX N/A
  • LDWY 425.12
  • 52 Week Low
  • TSBX $0.29
  • LDWY $3.02
  • 52 Week High
  • TSBX $2.65
  • LDWY $5.53
  • Technical
  • Relative Strength Index (RSI)
  • TSBX 53.01
  • LDWY 51.44
  • Support Level
  • TSBX $0.33
  • LDWY $4.50
  • Resistance Level
  • TSBX $0.37
  • LDWY $5.39
  • Average True Range (ATR)
  • TSBX 0.01
  • LDWY 0.36
  • MACD
  • TSBX -0.00
  • LDWY -0.02
  • Stochastic Oscillator
  • TSBX 74.50
  • LDWY 68.22

About TSBX Turnstone Biologics Corp.

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

About LDWY Lendway Inc. (DE)

Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.

Share on Social Networks: